Trade

with

Teva Pharmaceutical Industries Ltd
(NYSE: TEVA)
AdChoices
53.62
+0.02
+0.04%
After Hours :
53.60
-0.02
-0.04%

Open

53.72

Previous Close

53.60

Volume (Avg)

2.92M (3.76M)

Day's Range

53.01-54.15

52Wk Range

36.26-55.70

Market Cap.

45.77B

Dividend Rate (Yield )

- (2.19%)

Beta

0.63

Shares Outstanding

854.00M

P/E Ratio (EPS)

17.54 (3.04)

AdChoices
Financials
  • Income Statement
  • Balance Sheet
  • Cash Flow
Operating Income
1.65B
Operating Margin
8.12
Total Equity
-
Retained Earnings
-
Free Cashflow
-
Price/Cashflow
-
Ownership

Institutional Ownership

59.78%

Top 10 Institutions

23.36%

Mutual Fund Ownership

31.57%

Float

-

5% / Insider Ownership

-

Corporate insiders or major stockholders reporting trading activity in the stock.

Top Mutual Fund Owners

Top Institutional Owners

Mutual Fund Name

Institution Name

  • Mutual Fund Name

  • Shares Held

  • % Change

  • % Outstanding

  • VA CollegeAmerica EuroPacific Growth

  •  

    12,810,300

  • 0.00

  • 1.50

  • Franklin Mutual Global Discovery Fund

  •  

    8,737,113

  • 0.00

  • 1.02

  • VA CollegeAmerica Cap World Gr and Inc

  •  

    8,452,000

  • -10.78

  • 0.99

  • Vanguard Health Care Fund

  •  

    7,344,400

  • -40.54

  • 0.86

  • Franklin Mutual Shares Fund

  •  

    6,224,949

  • 0.00

  • 0.73

  • Templeton Growth Fund

  •  

    6,159,610

  • 0.64

  • 0.72

  • VA CollegeAmerica Invmt Co of America

  •  

    4,100,000

  • 0.00

  • 0.48

  • Fidelity® Diversified International Fund

  •  

    3,961,400

  • 0.00

  • 0.46

  • AllianzGI NFJ Dividend Value Fund

  •  

    3,572,200

  • 0.00

  • 0.42

  • Fidelity® Contrafund® Fund

  •  

    3,522,400

  • 6.26

  • 0.41

  • Institution Name

  • Shares Held

  • % Change

  • % Outstanding

  • Fidelity Management and Research Company

  •  

    37,909,048

  • +47.71%

  • 4.44

  • Capital Research Global Investors

  •  

    32,895,152

  • -24.18%

  • 3.85

  • Franklin Mutual Advisers, LLC

  •  

    24,051,510

  • -1.75%

  • 2.82

  • Invesco Advisers, Inc

  •  

    18,158,475

  • +39.78%

  • 2.13

  • Templeton Global Advisors Limited

  •  

    17,952,094

  • +34.61%

  • 2.10

  • Mondrian Investment Partners Ltd

  •  

    15,924,778

  • -8.03%

  • 1.86

  • Lazard Asset Management LLC

  •  

    15,283,002

  • +205.99%

  • 1.79

  • Wellington Management Company, LLP

  •  

    14,029,142

  • -56.65%

  • 1.64

  • PointState Capital LP

  •  

    12,475,105

  • -2.05%

  • 1.46

  • Barrow, Hanley, Mewhinney & Strauss LLC.

  •  

    10,868,770

  • -18.50%

  • 1.27

Company Profile

Sector

Healthcare

Industry

Drug Manufacturers – Specific & Generic

Type

Speculative Growth

Style

Large Value

Teva Pharmaceutical Industries Ltd was incorporated in Israel on February 13, 1944. The Company manufactures generic pharmaceutical products. It operates in business in two segments such as generic products, which includes chemical a...morend therapeutic equivalents of originator pharmaceuticals in a variety of dosage forms, including tablets, capsules, ointments, creams, liquids, injectables and inhalants, as well as API business; and specialty products, which includes several core franchises, medicines for CNS disorders (with a strong emphasis on MS, neurodegenerative disorders, and pain) and respiratory medicines, as well as other areas such as oncology and women’s health. In addition to these two segments, the Company has other activities, primarily PGT Healthcare, OTC joint venture with P&G, distribut...moreion services primarily in Israel and Hungary, and sales of medical devices. The Company, along with its subsidiaries operates in approximately 60 countries. It develops, manufactures and sell generic pharmaceutical products in a variety of dosage forms, including tablets, capsules, ointments, creams, liquids, injectables and inhalants. Specialty medicines business, which is focused on delivering solutions to patients and providers via medicines, devices and services in all key regions and markets around the world, includes several core therapeutic areas, medicines for CNS disorders (with a strong emphasis on MS, neurodegenerative disorders, and pain) and respiratory medicines. Some of its products are Copaxone, Azilect & Provigil, among others. The Company markets approximately 375 generic products in more than 1,100 dosage strengths and packaging sizes, including oral, injectables and inhaled products. The Company is subject to extensive regulation by the United States federal government, principally by the FDA and the Drug Enforcement Administration (“DEA”).lessless

Key People

Carlo De Notaristefani,PhD

CEO, Divisional/President, Divisional

Judith Vardi

CEO, Geographical/President, Geographical

Mr. Erez Vigodman

Director/President/CEO

Robert Koremans

CEO, Geographical/President, Geographical

Mr. Allan Oberman

CEO, Subsidiary/President, Subsidiary

Incorporated

1944

Employees

-

Send Feedback

We appreciate your input!

  • I'm having trouble signing into my Microsoft account

  • I’m having problems with the services stripe (Mail, Facebook, etc.)

  • There is an issue with my weather information

  • I see an error in the content

  • Other

Please give an overall site rating: